2. UroToday Home
  3. Video Lectures

ESMO 2024 Videos

Belzutifan vs Everolimus Trial Data in Advanced RCC Care - Brian Rini
October 30, 2024
Details
ARROW Study Reveals Iodine-131 PSMA Efficacy in Advanced Cancer - Evan Yu
October 30, 2024
Details
Metformin Study Reveals Weight Management Benefits for ADT Therapy - Silke Gillessen
October 30, 2024
Details
LEGEND Trial Investigates EG-70 in Bladder Cancer Patients - Gautier Marcq
October 18, 2024
Details
STAMPEDE2 Trial Explores Combination Niraparib and Abiraterone in mHSPC - Sarah Howlett & Mahaz Kayani
October 15, 2024
Details
EV-302 Trial Analysis Evaluating Nectin-4 in Urothelial Cancer - Thomas Powles
October 11, 2024
Details
NIAGARA Trial: Chemo Plus Durvalumab Improves Survival in Muscle-Invasive Bladder Cancer - Thomas Powles
October 11, 2024
Details
Masofaniten in Prostate Cancer Phase 1/2 Trial: Data and Future Directions - Christos Kyriakopoulos
October 9, 2024
Details
JCOG1019 Trial Examines Watchful Waiting vs BCG for High-Grade T1 Bladder Cancer - Hiroshi Kitamura
October 9, 2024
Details
Oligometastatic vs Oligoprogressive RCC Treatment Strategies - Chad Tang
October 7, 2024
Details
Advancing mHSPC Treatment Options: ARANOTE Trial Analysis - Neal Shore & Fred Saad
October 7, 2024
Details
INSPIRE Trial Investigates Immunotherapy for Molecularly Selected Advanced Prostate Cancer - Niven Mehra
October 7, 2024
Details
Variant Histology Bladder Cancer Challenges and Future Directions - Syed Hussain
October 7, 2024
Details
Highlights in Non-Prostate GU Oncology from ESMO 2024 - Ignacio Duran
October 4, 2024
Details
STEAP1-Targeted T-Cell Engager Demonstrates Efficacy in mCRPC Patients - William Kevin Kelly
October 3, 2024
Details
Emerging DLL3-Targeted Therapies Demonstrate Efficacy in Neuroendocrine Prostate Cancer - Himisha Beltran
October 3, 2024
Details
Novel Epigenomic Liquid Biopsy Detects PSMA Expression in Prostate Cancer - Jacob Berchuck
October 2, 2024
Details
Enfortumab Vedotin and Stereotactic Radiation Tested Before Surgery in Muscle-Invasive Bladder Cancer in STAR-EV Trial - Tian Zhang
October 2, 2024
Details
Event-Free Survival as Surrogate Endpoint in Muscle Invasive Bladder Cancer Research - Cora Sternberg
October 1, 2024
Details
Advancements in Lutetium-PSMA Therapy for Prostate Cancer: Clinical Trials and Future Directions - Ken Herrmann
October 1, 2024
Details
Decipher® in mHSPC: Guiding Risk Assessment and Treatment Intensification - Gerhardt Attard
October 1, 2024
Details
First-in-Class AR Degrader Shows Promise in Castration-Resistant Prostate Cancer - Dana Rathkopf
October 1, 2024
Details
TALAPRO-2 Analysis: Talazoparib Enzalutamide Combo in Pretreated mCRPC - Neeraj Agarwal
September 30, 2024
Details
CONTACT-02 Trial Results: Cabozantinib Plus Atezolizumab for mCRPC - Neeraj Agarwal
September 30, 2024
Details
PEACE 3 Trial Results Show Promise for Radium-223 and Enzalutamide in Asymptomatic mCRPC - Fred Saad
September 28, 2024
Details
Accelerated 177Lu-PSMA-617 Protocol Tested in STAMPEDE2 - Minal Padden-Modi & Nicholas James
September 27, 2024
Details
SunRISe-1 Trial Advances Bladder Cancer Treatment with TAR-200 - Michiel Van der Heijden
September 27, 2024
Details
PATCH Trial Evaluates Transdermal Estradiol in Non-Metastatic Prostate Cancer - Duncan Gilbert
September 26, 2024
Details
RAPSON Trial Explores Radium223 and Docetaxel Sequencing in mCRPC - Vincenza Conteduca
September 26, 2024
Details
Darolutamide Improves Outcomes for mHSPC Patients in ARANOTE Trial - Fred Saad
September 26, 2024
Details
PEACE-3 Trial Results: Radium-223 + Enzalutamide in mCRPC - Bertrand Tombal
September 24, 2024
Details
STAMPEDE2 SABR Trial for Oligometastatic Prostate Cancer Treatment - Hoda Abdel-Aty
September 24, 2024
Details
UpFrontPSMA Trial: Lutetium-PSMA + Docetaxel in mHSPC - Arun Azad
September 23, 2024
Details
Glycoproteomics in Kidney Cancer: CheckMate 9ER Biomarker Analysis - David Braun
September 23, 2024
Details
T-Cell Engagers in Prostate Cancer Treatment - Neeraj Agarwal
September 22, 2024
Details
Bladder Cancer Breakthroughs in SunRISe-1, AMBASSADOR, and VOLGA Trials - Maria De Santis
September 21, 2024
Details
Tumor Suppressor Gene Signature Predicts Early Progression in mHSPC - Marta Garcia de Herreros
September 20, 2024
Details
CaboPoint Trial: Cabozantinib in Second-Line RCC Treatment - Laurence Albiges
September 19, 2024
Details
EMBARK Trial: Age-Stratified Analysis of Enzalutamide in High-Risk Biochemically Recurrent Prostate Cancer - Neal Shore
September 19, 2024
Details
ZZ-FIRST Trial Demonstrates High PSA Response with Combination Therapy - Joaquin Mateo
September 18, 2024
Details
ARANOTE Study: Transforming Metastatic Hormone Sensitive Prostate Cancer Treatment - Fred Saad
September 16, 2024
Details
PEACE-1 Trial Reveals Key Genomic Alterations Linked to Survival in Prostate Cancer Patients - Cédric Pobel
September 16, 2024
Details
SunRISe-4 Trial Explores TAR-200 and Cetrelimab Combination for Bladder Cancer Treatment - Andrea Necchi
September 16, 2024
Details
Fecal Microbiota Transplant Boosts Immunotherapy in Metastatic Renal Cell Carcinoma in TACITO-II Trial - Chiara Ciccarese
September 15, 2024
Details
Disitamab Vedotin: Promising HER2-Targeted Therapy for Urothelial Cancer - Matthew Galsky
September 15, 2024
Details
PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT - Michael Hofman
September 15, 2024
Details
COTRIMS Trial Shows High Cure Rates with RPLND in Stage IIA/B Seminoma - Axel Heidenreich
September 15, 2024
Details
AMBASSADOR Trial: Extended Follow-up on Adjuvant Pembrolizumab in Bladder Cancer - Andrea Apolo
September 15, 2024
Details
SPLASH Trial Highlights Radiopharmaceutical Lutetium-177’s Role in Advanced Prostate Cancer Treatment - Oliver Sartor
September 15, 2024
Details
NKT2152: Promising New HIF-2 Alpha Inhibitor for Advanced Renal Cell Carcinoma - Eric Jonasch
September 13, 2024
Details
TiNivo-2 Trial Results in Advanced Renal Cell Carcinoma Treatment - Toni Choueiri
September 13, 2024
Details
Genetic Profiles in Early vs. Late Stage Urothelial Cancer - Dag Stormoen
September 15, 2024
Details